Correlation Between Inhibrx and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Black Diamond Therapeutics, you can compare the effects of market volatilities on Inhibrx and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Black Diamond.
Diversification Opportunities for Inhibrx and Black Diamond
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Inhibrx and Black is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Inhibrx i.e., Inhibrx and Black Diamond go up and down completely randomly.
Pair Corralation between Inhibrx and Black Diamond
Given the investment horizon of 90 days Inhibrx is expected to generate 10.94 times less return on investment than Black Diamond. But when comparing it to its historical volatility, Inhibrx is 2.64 times less risky than Black Diamond. It trades about 0.01 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 236.00 in Black Diamond Therapeutics on September 3, 2024 and sell it today you would earn a total of 29.00 from holding Black Diamond Therapeutics or generate 12.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Inhibrx |
| Black Diamond Therap |
Inhibrx and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Black Diamond
The main advantage of trading using opposite Inhibrx and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |